Form 4 for PSNL Personalis, Inc.
Accepted 2026-07-15 21:27:39 ET · period of report 2026-07-15 · accession 0001779787-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-15 21:27 | 2026-07-15 | PSNL | Chen Richard | Pres, CMO | M - OptEx | $2.44 | +100.0K | 273.9K | +58% | +$244.0K |
| DT | 2026-07-15 21:27 | 2026-07-15 | PSNL | Chen Richard | Pres, CMO | S - Sale+OE | $15.15 | -100.0K | 173.9K | -37% | -$1.51M |
| DT | 2026-07-15 21:27 | 2026-07-15 | PSNL | Chen Richard | Pres, CMO | M - OptEx | $0.00 | -100.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-15 | M | A | 100,000 | $2.44 | 273,880 | D | — | — | (F1) The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. |
| 2 | Common | Common Stock | 2026-07-15 | S | D | 100,000 | $15.15 | 173,880 | D | — | — | (F1) The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. (F2) The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $15.01 to $15.45 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| 3 | Derivative | Stock Option (right to buy) | 2026-07-15 | M | D | 100,000 | $0.00 | 0 | D | $2.44 · — to 2027-05-24 | 100,000 Common Stock | (F1) The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. (F3) The shares subject to the option are fully vested and exercisable. |